Cite Filings / CADL / 0001950047-25-002014

Feed Companies Filings Check

Sign in

144

Sale of Securities

Candel Therapeutics, Inc. Filed 2025-03-18 Acc 0001950047-25-002014

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-06-30 144 Sale of Securities
2025-03-19 4 Chief Technology Officer sold 31,278 shares at $8.82 ($275,947)
2025-03-18 144 Sale of Securities
2025-03-18 144 Sale of Securities
2025-03-18 144 Sale of Securities
2025-03-17 144 Sale of Securities
2025-03-17 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…